how big is the glp 1 market GLP-1 Analogues Size, Share & Forecast Report, 2034 GLP-1 Weight Loss Drug Market

Meanwhile, users of weight-loss therapies based on GLP-1 agonists were warned to be aware of a rare complication, pancreatitis, which can be severe

References and citations Centers for Medicare & Medicaid Services

Latest Ozempic Lawsuit Updates As of July 2026, there are 3,848 personal injury lawsuits for gastroparesis, ileus and intestinal obstruction in MDL 3094 in the Eastern District of Pennsylvania

The National Institute for Health and Care Excellence (NICE) provides guidance on the use of GLP-1 receptor agonists in guideline NG28, recommending them for type 2 diabetes in specific contexts, such as when other therapies have proven inadequate, particularly in people with higher BMI or cardiovascular risk factors

13 As a result, initiation of therapy may be more beneficial for patients who require greater glycemic control throughout the day than during the night